Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

J. B. Ravzatov

7 ta ish

Andijon Davlat Tibbiyot Instituti

AkademScholarda batafsil koʻrsatkichlar

  1. Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection

    M. A. Zhuraeva, Владимир Алексеевич Алейник, N. D. Ashuralieva +3

    MaqolaOchiq kirishNeuropeptides and Animal PhysiologyRussian Journal of Infection and Immunity20210 iqtibos
    ABI

  2. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    MaqolaLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  3. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    MaqolaOchiq kirishLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  4. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    MaqolaOchiq kirishLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  5. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    MaqolaOchiq kirishLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  6. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    MaqolaLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  7. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    MaqolaLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI